Springer Healthcare news from the CTAD Conference
Dementia ResearcherSpringer Healthcare were at the CTAD Conference earlier this month. Check out this post for news from the event and updates on anti-amyloid treatments
Research News
SPIN-D: Building Connections for Inclusive Dementia Care
Watch the launch of the SPIN-D network +. Exploring community engagement and innovative approaches to support inclusive, person-centred dementia care.
Exploring New Social Horizons: X-odus to BlueSky Social
Explore why dementia researchers are joining Bluesky—a values-driven, customisable social media space. Follow us for updates @dementiaresearcher.bsky.social
European Medicines Agency changes opinion on Lecanemab
Following a re-examination of its initial opinion, EMA issues a positive opinion on authorisation of Lecanemab / Leqembi for the treatment of early Alzheimer’s
Recommendations to Make Dementia Studies More Inclusive
Alzheimer's AssociationNew ISTAART PIA position paper to help researchers understand how best to partner with communities to encourage inclusive research.
Amyloid Plaques Turn More Toxic as They Age
Alz ForumCombining isotopic labeling and transcriptomics, scientists found that mature plaques in mice wreaked more havoc on surrounding synapses than immature ones.
NIHR ARC Series on Health Inequalities
NIHRCatch-up on this years NIHR ARC webinar recordings exploring Health Inequalities through a lens of Early Life, Later Life, LGBTQ+ Communities and more
Revised diagnostic criteria for Alzheimer’s Published
New diagnostic criteria for Alzheimer’s presented at the Clinical Trials on Alzheimer’s Disease Conference in Madrid on behalf of International Working Group
Frailty: Research shows how to improve care
Discover NIHR’s latest insights on frailty & its impact. Evidence-based strategies help improve care quality, reduce hospital admissions & support independence
Donanemab fails UK NICE Approval Evaluation
NICE says evidence is needed on the clinical and cost-effectiveness of donanemab, a new treatment for mild Alzheimer’s disease.
Highlights from Lausanne XI
Highlights from the Lausanne XI Conference – ideas, diverse perspectives, and deep expertise from prevention to treatments.
Livestream Recording: Innovating with Alzheimer’s Society
Livestream with Alzheimer’s Society talking about their Launchpad and Innovation Programmes, three Innovators turning ideas into products and services